Belimumab Aids Anti-dsDNA & #43;, Hypocomplementemic Lupus

MONDAY, April 23, 2018 -- Weekly belimumab is associated with greater benefit than placebo for patients with hypocomplementemic/anti-double stranded (ds)DNA-positive systemic lupus erythematosus (SLE), according to a study published online April 18...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news